Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

Inclusion Criteria:

1. Diagnosis criteria of MS fulfilling revised Mc Donald criteria (2010)

2. Uni-or bilateral optic neuropathy with worst eye VA≤ 5/10 confirmed at 6 months

3. Worsening of visual acuity during the last three years

4. Informed consent prior to any study procedure

5. Patient aged 18-75 years

Exclusion Criteria:

1. Optic neuritis relapse within the three months before inclusion

2. Normal RNFL at OCT

3. Presence of other ocular pathology (glaucoma, cataract, retinopathy, anterior uveitis,myopia>7 dioptrics, intraocular pressure>20 mm Hg, amblyopia, retinal or optic headabnormalities (drusen, tilted disc)

4. Bilateral visual acuity <1/20

5. Visual impairment caused by ocular flutter or nystagmus

6. Pregnancy or childbearing potential woman without contraception

7. Any general chronic handicapping disease other than MS

8. New treatment introduced less than 3 months prior to inclusion or less than 1 monthfor Fampridine